- Login
- Register & Subscribe
- Langue: EN FR DE
Saturday 4 May 2013
The European Medicines Agency has announced plans to change its structure from August in order to respond to public demands for more pharmaceutical data and to give stronger support to industry in the research and development of new drugs.
Country: United Kingdom
Saturday 4 May 2013
Tissue Regenix Plc of the UK said that a trial of its skin graft in patients with chronic leg ulcers healed wounds in more than half of the patients tested. The trial results are being presented this week at the Symposium on Advanced Wound Care in the US.
Country: United Kingdom
Saturday 4 May 2013
Lundbeck A/S has confirmed that revenue and earnings this year will be broadly in line with those in 2012, excluding the cost of restructuring. The impact of generic competition is expected to be offset by new product sales and divestitures.
Country: Denmark
Friday 3 May 2013
MorphySys AG increased its revenue by 44% to €16.9 million in the first quarter of 2013 primarily due to a license payment from the purchaser of its AbD Serotec service business. The German company swung into a profit after a year-earlier loss.
Country: Germany
Thursday 2 May 2013
GW Pharmaceuticals Plc, which has developed a cannabinoid-based product for treating spasticity due to multiple sclerosis, has priced an initial public offering of its shares at $8.90 per American Depository Share. The shares will trade on NASDAQ.
Country: United Kingdom
Thursday 2 May 2013
Shire Plc has announced a reorganisation of its marketing and research activities following the recent appointment of a new chief executive, Flemming Ornskov. Dr Ornskov joined Shire at the start of the year and officially became chief executive in April.
Country: Ireland
Thursday 2 May 2013
Symphogen A/S of Denmark has raised an additional €41 million from private investors towards the development of its portfolio of compounds in oncology which are antibody mixture products addressing multiple targets in a single product.
Country: Denmark
Thursday 2 May 2013
Sanofi continued to suffer from generic competition as sales declined 5.3% to €8.1 billion in the first quarter and operating income plunged by 33.5% to €1.5 billion. Business net income, a non-GAAP financial measure, fell by 33.5% to €1.61 billion.
Country: France
Wednesday 1 May 2013
Novo Nordisk reported a 13% rise in sales in the first quarter of 2013 to DKK 20 billion (€2.7 billion) and an 18% increase in operating profit to DKK 7.6 billion as a result of continuing strong sales of diabetes products in the US.
Country: Denmark
Wednesday 1 May 2013
Oxford BioMedica Plc has signed a contract with Novartis to supply the Swiss company with lentiviral vector material for clinical trials involving a new immunotherapy. The contract is valued at up to £4 million.
Country: United Kingdom
Monday June 10 2013
Monday June 10 2013
Thursday June 6 2013
Thursday June 6 2013
Thursday June 6 2013